Potentially inappropriate medication use in a comprehensive therapy management service
clinical outcomes and interventions
DOI:
https://doi.org/10.1590/s2175-97902022e19191Keywords:
Brazil, Aged, Medication therapy management, Potentially inappropriate medication list, Pharmaceutical careAbstract
This study aimed to describe potentially inappropriate medication (PIM) use according to the Beers criteria among older adults followed in a comprehensive medication management (CMM) service, the pharmacists´ interventions, and the clinical outcomes of PIM use. All older adults in a CMM service delivered in the Brazilian public primary care system were included in the study (n = 389). Two methodological approaches were developed: (I) cross-sectional - prevalence of PIM use and associated factors were identified (univariate analysis - Pearson’s chi-square; multivariate - logistic regression); (II) documental analysis of the negative clinical outcomes potentially associated with PIM use and pharmacists’ interventions. The prevalence of PIM use was 48.3%, and it was independently and positively associated with the use of ≥ 5 drugs. For 21.3% of PIMs, a potential negative clinical outcome was identified. The most common negative clinical outcome was hypotension (35.1% of the negative outcomes), fractures or diagnosis of osteoporosis (21.1%), and hypoglycemia (14.0%). For most of them (78.9%), an intervention was performed to mitigate harm or discontinue use. A high prevalence of PIM was detected and was associated with polypharmacy. A significant proportion of PIM showed potential negative clinical outcomes that were identified by clinical pharmacists, and the majority of pharmacists’ interventions aimed at its mitigation or deprescription. Overall, our findings reinforce the potential of CMM services for reducing PIM use and the occurrence of negative outcomes.
Downloads
References
AGS. American Geriatrics Society. American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227-46.
AGS. American Geriatrics Society. American Geriatrics Society 2019 updated AGS Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc . 2019;67(4):674-94.
Almeida TA, Reis EA, Pinto IVL, Ceccato MDGB, Silveira MR, Lima MG, Reis AMM. Factors associated with the use of potentially inappropriate medications by older adults in primary health care: An analysis comparing AGS Beers, EU(7)-PIM List, and Brazilian Consensus PIM criteria. Res Social Adm Pharm. 2019;15(4):370-7.
Alvarenga JM, Loyola Filho A, Firmo JOA, Lima-Costa MF, Uchoa E. Prevalence and sociodemographic characteristics associated with benzodiazepines use among community dwelling older adults: the Bambuí Health and Aging Study (BHAS). Rev Bras Psiquiatr. 2007;30(1):7-11.
Awad A, Hanna O. Potentially inappropriate medication use among geriatric patients in primary care setting: A cross-sectional study using the Beers, STOPP, FORTA and MAI criteria. PLoS One. 2019;14(6):e0218174.
Blanco-Reina E, Ariza-Zafra G, Ocaña-Riola R, Leõn-Ortiz M. 2012 American Geriatrics Society Beers criteria: Enhanced applicability for detecting potentially inappropriate medications in European older adults? A comparison with the screening tool of older person’s potentially inappropriate prescriptions. J Am Geriatr Soc . 2014;62(7):1217-23.
Brasil. Ministério da Saúde. Relação Nacional de Medicamentos Essenciais [Internet]. Brasília (DF): Ministério da Saúde, 2017. 24 p. Available from: http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sih/cnv/niuf.def
» http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sih/cnv/niuf.def
Brunoni AR, Nunes MA, Figueiredo R, Barreto SM, Fonseca MDJM, Lotufo PA, et al. Patterns of benzodiazepine and antidepressant use among middle-aged adults. the Brazilian longitudinal study of adult health (ELSA-Brasil). J Affect Disord. 2013;151(1):71-7.
Caffiero N, Delate T, Ehizuelen MD, Vogel K. Effectiveness of a clinical pharmacist medication therapy management program in discontinuation of drugs to avoid in the elderly. J Manag Care Spec Pharm. 2017;23(5):525-31.
Chiapella LC, Menna JM, Marzi M, Mamprin ME. Prevalence of potentially inappropriate medications in older adults in Argentina using Beers criteria and the IFAsPIAM List. Int J Clin Pharm. 2019. doi: 10.1007/s11096-019-00858-8. [Epub ahead of print].
» https://doi.org/10.1007/s11096-019-00858-8
Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice: the clinician’s guide. 2nd ed, New York: McGraw-Hill. 2004.
De Vries M, Seppala LJ, Daams JG, Van de Glind EMM, Masud T, Van der Velde N, et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: I. Cardiovascular Drugs. J Am Med Dir Assoc. 2018;19(4):371.e1-371.e9
Extavour RM, Perri M. Patient, Physician, and health-system factors influencing the quality of antidepressant and sedative prescribing for older, community-dwelling adults. Health Serv Res. 2016;2040:1-25.
Farrell B, Pottie K, Thompson W, Boghossian T, Pizzola L, Rashid F, et al. Deprescribing proton pump inhibitors: evidence-based clinical practice guideline. Can Fam Physician. 2017;63:354-64.
Filardi AFR, Araújo VE, Nascimento YDA, Ramalho de Oliveira D. Use of psychotropics in everyday life from the perspective of health professionals and patients: a systematic review. J Crit Rev. 2017;4(3):1.
Freedberg DE, Kim LS, Yang YX. The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association. Gastroenterol. 2017;152(4):706-15.
Gisev N, Hartikainen S, Chen TF, Korhonen M, Bell JS. Mortality associated with benzodiazepines and benzodiazepine-related drugs among community-dwelling older people in Finland: A population-based retrospective cohort study. Can J Psychiatry. 2011;56(6):377-81.
Gonçalves LHT, Alvarez AM, Sena ELS, Santa LWS, Vicente FR. Profile of the family caregiver for frail/sick elderly in the sociocultural context of Florianópolis, SC. Texto Contexto Enferm. 2006;15(4):570-7.
Grina D, Briedis V. The use of potentially inappropriate medications among the Lithuanian elderly according to Beers and EU(7)-PIM list - a nationwide cross-sectional study on reimbursement claims data. J Clin Pharm Ther. 2017;42(2):195-200.
Gurwitz JH. Polypharmacy: a new paradigm for quality drug therapy in the elderly? Arch Intern Med. 2004;164:1957-9.
Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5(4):345-51.
Hanlon JT, Semla TP, Schmader KE. Alternative medications for medications included in the use of high-risk medications in the elderly and potentially harmful drug-disease interactions in the elderly quality measures. J Am Geriatr Soc . 2015;63(13):8-18.
Hartholt KA, Lee R, Burns ER, Van Beek EF. Mortality from falls among US adults aged 75 years of older, 2000-2016. JAMA. 2019;321(21):2131-3.
Huang AR, Mallet L, Rochefort CM, Eguale T, Buckeridge DL, Tamblyn R. Medication-related falls in the elderly: Causative factors and preventive strategies. Drugs Aging. 2012;29(5):359-76.
IBGE. Síntese de indicadores sociais - uma análise das condições de vida da população brasileira. estudo e pesquisa - informação demográfica e socioeconômica. Rio de Janeiro (RJ): IBGE, 2013. Available from: http://biblioteca.ibge.gov.br/visualizacao/livros/liv66777.pdf
» http://biblioteca.ibge.gov.br/visualizacao/livros/liv66777.pdf
James M, Kumar AB. The risk of long-term use of proton pump inhibitors: acritical review. Ther Adv Drug Safe. 2018;10: 2042098618809927.
Kim GJ, Lee KH, Kim JH. South Korean geriatrics on Beers criteria medications at risk of adverse drug events. PLoS One . 2018;13(3):1-24.
Lader M. Benzodiazepine harm: how can it be reduced? Br J Clin Pharmacol. 2014;77(2):295-301.
Maurício VMDO, Mendonça S AM, Nascimento MMG, Ramalho de Oliveira D. Potentially inappropriate medication use among Brazilian elderly in a medication management program. J Basic Appl Pharm Sci. 2016;37(1):1-8.
Moriarty F, Bennett K, Fahey T, Kenny RA, Cahir C. Longitudinal prevalence of potentially inappropriate medicines and potential prescribing omissions in a cohort of community-dwelling older people. Eur J Clin Pharmacol. 2015;71(4):473-82.
Motter FR, Fritzen JS, Hilmer SN, Paniz ÉV, Paniz VMV. Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria. Eur J Clin Pharmacol . 2018;74(6):679-700.
Nascimento MMG, Lima-Costa MF, Loyola Filho A. Potentially inappropriate medication use among brazilian elderly: a population-based pharmacoepidemiological study. Lat Am J Pharm. 2016;35(4):659-66.
Nascimento MMG, Mambrini JVM, Lima-Costa MF, Firmo JOA, Peixoto SWV, de Loyola Filho AI. Potentially inappropriate medications: predictor for mortality in a cohort of community-dwelling older adults. Eur J Clin Pharmacol . 2017;73(5):615-21.
Nishtala PS, Bagge ML, Campbell AJ, Tordoff JM. Potentially inappropriate medicines in a cohort of community-dwelling older people in New Zealand. Geriatr Gerontol Int. 2014;14(1):89-93.
Novaes PH, Cruz DT, Lucchetti ALG, Leite ICG, Lucchetti G. Comparison of four criteria for potentially inappropriate medications in Brazilian community-dwelling older adults. Geriatr Gerontol Int . 2017;17(10):1628-35.
O’Mahony D, Gallagher P, Ryan C, Byrne S, Hamilton H, Barry P, et al. STOPP & START criteria: a new approach to detecting potentially inappropriate prescribing in old age. Eur Geriatr Med. 2010;1(1):45-51.
Patel R, Zhu L, Sohal D, Lenkova E, Koshki N, Woelfel J, et al. Use of 2015 Beers criteria medications by older medicare beneficiaries. Am Soc Consult Pharm. 2018;33(1):48-54.
Paterniti S, Dufouil C, Alperovitch A. Long-term benzodiazepine use and cognitive decline in the elderly: the epidemiology of vascular aging study. J Clin Psychopharmacol. 2002;22(3):285-93.
Pezeshkian S, Conway SE. Proton Pump Inhibitor Use in Older Adults: Long-Term Risks and Steps for Deprescribing. Consult Pharm. 2018;33(9):497-503.
Pottie K, Thompson W, Davies S, Grenier J, Sadowski CA, Welch V, et al. Deprescribing benzodiazepine receptor agonists. Can Fam Physician . 2018;64(5):339-51.
Price SD, Holman CDAJ, Sanfilippo FM, Emery JD. Association between potentially inappropriate medications from the Beers criteria and the risk of unplanned hospitalization in elderly patients. Ann Pharmacother. 2014;48(1):6-16.
Savarino V, Dulbecco P, Bortoli N, Ottonello A, Savarino E. The appropriate use of proton pump inhibitors (PPIs): need for a reappraisal. Eur J Intern Med. 2017;37:19-24.
Schmidt MI, Duncan BB, Silva GA, Menezes AM, Monteiro CA, Barreto SM, et al. Chronic non-communicable diseases in Brazil: burden and current challenges. Lancet. 2011;377(9781):1949-61.
Seppala LJ, Wemelink AMAT, De Vries M, Proegmakers KJ, Van de Glind EMM, Daams JG, et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: II. Psychotropics. J Am Med Dir Assoc . 2018 Apr;19(4):371.e11-371.e17.
Skaar DD, O’Connor HL. Using the Beers criteria to identify potentially inappropriate medication use by older adult dental patients. J Am Dent Assoc. 2017;148(5):298-307.
Spanemberg L, Nogueira EL, Belem da Silva CT, Dargél AA, Menezes FS, Neto AC. High prevalence and prescription of benzodiazepines for elderly: data from psychiatric consultation to patients from an emergency room of a general hospital. Gen Hosp Psychiatry. 2011;33(1):45-50.
Varallo FR, Oliveira FM, Mastroianni PC. Safety assessment of essential medicines for elderly people: A bibliographic survey. Braz J Pharm Sci. 2014; 50(2):269-84.
Vasconcelos AMN, Gomes MMF. Demographic transition: the Brazilian experience. Epidemiol Serv Saúde. 2012;21(4):539-48.
Veras R, Xavier F. E. Population aging today: demands, challenges and innovations. Rev Saúde Pública. 2009;43(33):548-54.
Viswanathan M, Kahwati LC, Golin CE, Blalock SJ, Coker-Schwimmer E, Posey R, et al. Medication therapy management interventions in outpatient settings. a systematic review and meta-analysis. Am Med Assoc. 2015;175(1):76-87.
Wennberg AM, Canham SL, Smith MT, Spira AP. Optimizing sleep in older adults: treating insomnia. Maturitas. 2013;76(3):247-52.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
